98%
921
2 minutes
20
Background: Globally, anemia poses a serious health challenge for children under the age of five, and Ethiopia is one of the countries significantly affected by this issue. The 2016 Ethiopian Demographic and Health Survey (DHS) data sets were employed to evaluate anemia risk among children aged 6-59 months. Due to limited research has been conducted on childhood anemia spatial disparities at the Ethiopian zonal level, and it is essential for developing zonal-level interventions for inform policy recommendations.
Methods: This study was examined the geospatial disparities in anemia prevalence among children aged 6-59 months. We used a semi-parametric additive model with spatial smoothing to assess zone-level variation in anemia risk while adjusting for key covariates. Each predictor variable was spatially adjusted using non-parametric smoothing techniques based on geolocation parameters, and corresponding maps for each predictor.
Results: A regularized random forest techniques was employed to identify the most influential predictors of childhood anemia and enhance the model predictive performance. Our findings revealed that the regional states of Somalia, Afar, and Dire Dawa exhibit the highest risk levels for childhood anemia. Furthermore, the risk of anemia in children varies spatially across different zones in Ethiopia. The most prominent hotspots for childhood anemia were in the country's Northeastern, Eastern, and Southeastern regions. In contrast, the areas with the lowest risk were in Northwestern, Western, and Southwestern zones of Ethiopia.
Conclusion: The significant spatial disparities in anemia risk across the administrative zones of Ethiopia, indicating that the distribution of each predictor variable is not uniform. These findings provide valuable insights for policymakers, enabling the development of geographically targeted interventions to mitigate anemia risk at the zonal level.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12408295 | PMC |
http://dx.doi.org/10.3389/fped.2025.1559140 | DOI Listing |
Turk J Pediatr
September 2025
Division of Pediatric Rheumatology, Department of Pediatrics, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Türkiye.
Background: We aimed to document childhood onset mevalonate kinase deficiency (MKD) and to explore treatment responses and diagnostic challenges in regions endemic to familial Mediterranean fever (FMF).
Methods: This retrospective study included patients under 18 years of age, diagnosed with MKD and followed for at least six months at the pediatric rheumatology department of Istanbul University - Cerrahpaşa Medical Faculty between 2016 and 2024.
Results: Of 33 patients, 51.
Turk J Pediatr
September 2025
Department of Pediatric Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye.
Backround: Leukemia is the most common childhood malignancy and often presents with nonspecific symptoms, which may lead to delays in diagnosis. Early recognition of clinical signs and laboratory abnormalities is essential to ensure timely referral and improve outcomes. This study assesses the clinical and laboratory characteristics of pediatric patients with acute and relapsed leukemia, points out key considerations during diagnosis, and investigates potential factors contributing to delayed diagnosis.
View Article and Find Full Text PDFFront Pediatr
August 2025
Department of Statistics, University of Pretoria, Pretoria, South Africa.
Background: Globally, anemia poses a serious health challenge for children under the age of five, and Ethiopia is one of the countries significantly affected by this issue. The 2016 Ethiopian Demographic and Health Survey (DHS) data sets were employed to evaluate anemia risk among children aged 6-59 months. Due to limited research has been conducted on childhood anemia spatial disparities at the Ethiopian zonal level, and it is essential for developing zonal-level interventions for inform policy recommendations.
View Article and Find Full Text PDFLancet Haematol
September 2025
Department of Paediatrics and Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Cureus
July 2025
Neonatal Intensive Care Unit, Mohammed VI University Hospital Center, Marrakech, MAR.
Kasabach-Merritt syndrome (KMS) is a rare and potentially life-threatening pediatric coagulopathy characterized by thrombocytopenia, microangiopathic hemolytic anemia, and coagulation abnormalities. Clinically, it presents as a reddish-purple mass resembling a hemangioma. Diagnosis relies on a combination of clinical and biological assessments, sometimes supplemented by biopsy to confirm the hemangioma.
View Article and Find Full Text PDF